Fred Hutchinson Cancer Research Center's Dr. Ruth Etzioni and colleagues show aggressive treatment confers only modest extension of life; model confirms active surveillance offers patients years free of treatment and side effects
Basic Sciences researcher’s innovative mathematical analysis of fundamental biology garners $1.5 million in funding
Sept. 28, 2009
| By Colleen Steelquist
For her novel work analyzing cooperative systems and cheater mechanisms in yeast cells, Dr. Wenying Shou is the first Fred Hutchinson Cancer Research Center investigator to win a National Institutes of Health New Innovator Award. The three-year-old program, which encourages high-risk research and innovation for early stage investigators, granted 55 awards nationwide. Shou’s five-year award is worth up to $1.5 million.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.